STRS Ohio’s Apogee Therapeutics APGE Stock Holding History

STRS Ohio’s Portfolio APGE Stock Details APGE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	–	Sell	-8,500	Closed	-$1.13M	–	2217
2026 Q2	$1.13M	Buy	8,500 +4,100	+93%	+$369K	﹤0.01%	682
2026 Q1	$370K	Buy	4,400 +1,100	+33%	+$79.9K	﹤0.01%	1237
2025 Q4	$249K	Buy	+3,300	New	+$208K	﹤0.01%	1421
2025 Q1	–	Sell	-5,500	Closed	-$249K	–	1933
2024 Q4	$249K	Sell	5,500 -600	-10%	-$30.6K	﹤0.01%	1430
2024 Q3	$358K	Hold	6,100	–	–	﹤0.01%	1392
2024 Q2	$240K	Buy	6,100 +2,200	+56%	+$107K	﹤0.01%	1513
2024 Q1	$259K	Sell	3,900 -200	-5%	-$8.73K	﹤0.01%	1484
2023 Q4	$114K	Hold	4,100	–	–	﹤0.01%	1674
2023 Q3	$87K	Buy	+4,100	New	+$90.3K	﹤0.01%	1735

Other funds holding APGE

IFP Advisors Tampa, Florida $5.86B AUM 20.09% 1-Year Est. Return

Allworth Financial Folsom, California $28.2B AUM 13.34% 1-Year Est. Return

STRS Ohio's APGE Position: Q3 2026 in Review

STRS Ohio sold out of Apogee Therapeutics (APGE) in Q3 2026, closing a stake of 8,500 shares — an estimated $1.13M sold.

STRS Ohio first reported a position in APGE in Q3 2023 and held it in 9 quarters. The position peaked at $1.13M in Q2 2026. 2 funds tracked by Wall St. Rank hold APGE as of Q3 2026.

STRS Ohio reported no remaining Apogee Therapeutics position as of Q3 2026 after selling out during the quarter.
STRS Ohio sold 8,500 Apogee Therapeutics shares in Q3 2026, an estimated $1.13M.
STRS Ohio first reported a position in Apogee Therapeutics in Q3 2023 and held it in 9 quarters.
STRS Ohio's Apogee Therapeutics position peaked at $1.13M in Q2 2026.
2 funds tracked by Wall St. Rank held Apogee Therapeutics as of Q3 2026.

Based on STRS Ohio's 13F filing for Q3 2026, filed 30 Oct 2026.